Literature DB >> 11238567

Modulation of MDR/MRP by wild-type and mutant p53.

O Bähr, W Wick, M Weller.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238567      PMCID: PMC363032          DOI: 10.1172/JCI12415

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  14 in total

1.  Wild-type p53-mediated induction of rat mdr1b expression by the anticancer drug daunorubicin.

Authors:  G Zhou; M T Kuo
Journal:  J Biol Chem       Date:  1998-06-19       Impact factor: 5.157

2.  Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo.

Authors:  L Rieger; J Rieger; S Winter; J Streffer; P Esser; J Dichgans; R Meyermann; M Weller
Journal:  Acta Neuropathol       Date:  2000-05       Impact factor: 17.088

3.  Melphalan resistance and photoaffinity labelling of P-glycoprotein in multidrug-resistant Chinese hamster ovary cells: reversal of resistance by cyclosporin A and hyperthermia.

Authors:  B Larrivée; D A Averill
Journal:  Biochem Pharmacol       Date:  1999-07-15       Impact factor: 5.858

4.  Regulation of expression of the multidrug resistance protein MRP1 by p53 in human prostate cancer cells.

Authors:  G F Sullivan; J M Yang; A Vassil; J Yang; J Bash-Babula; W N Hait
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

5.  Involvement of heat shock factor in regulating transcriptional activation of MDR1 gene in multidrug-resistant cells.

Authors:  S H Kim; W Y Hur; C D Kang; Y S Lim; D W Kim; B S Chung
Journal:  Cancer Lett       Date:  1997-05-01       Impact factor: 8.679

6.  Modulation of activity of the promoter of the human MDR1 gene by Ras and p53.

Authors:  K V Chin; K Ueda; I Pastan; M M Gottesman
Journal:  Science       Date:  1992-01-24       Impact factor: 47.728

7.  Chemosensitivity of human malignant glioma: modulation by p53 gene transfer.

Authors:  M Trepel; P Groscurth; U Malipiero; E Gulbins; J Dichgans; M Weller
Journal:  J Neurooncol       Date:  1998-08       Impact factor: 4.130

8.  'Gain of function' phenotype of tumor-derived mutant p53 requires the oligomerization/nonsequence-specific nucleic acid-binding domain.

Authors:  A Lányi; D Deb; R C Seymour; J H Ludes-Meyers; M A Subler; S Deb
Journal:  Oncogene       Date:  1998-06-18       Impact factor: 9.867

9.  Two critical hydrophobic amino acids in the N-terminal domain of the p53 protein are required for the gain of function phenotypes of human p53 mutants.

Authors:  J Lin; A K Teresky; A J Levine
Journal:  Oncogene       Date:  1995-06-15       Impact factor: 9.867

10.  The core promoter region of the P-glycoprotein gene is sufficient to confer differential responsiveness to wild-type and mutant p53.

Authors:  R L Zastawny; R Salvino; J Chen; S Benchimol; V Ling
Journal:  Oncogene       Date:  1993-06       Impact factor: 9.867

View more
  10 in total

1.  64Cu-labeled 2-(diphenylphosphoryl)ethyldiphenylphosphonium cations as highly selective tumor imaging agents: effects of linkers and chelates on radiotracer biodistribution characteristics.

Authors:  Chang-Tong Yang; Young-Seung Kim; Jianjun Wang; Lijun Wang; Jiyun Shi; Zi-Bo Li; Xiaoyuan Chen; Ming Fan; Jian-Jian Li; Shuang Liu
Journal:  Bioconjug Chem       Date:  2008-09-03       Impact factor: 4.774

2.  Evaluation of 64Cu-labeled acridinium cation: a PET radiotracer targeting tumor mitochondria.

Authors:  Yang Zhou; Young-Seung Kim; Jiyun Shi; Orit Jacobson; Xiaoyuan Chen; Shuang Liu
Journal:  Bioconjug Chem       Date:  2011-03-17       Impact factor: 4.774

3.  Forced expression of heat shock protein 27 (Hsp27) reverses P-glycoprotein (ABCB1)-mediated drug efflux and MDR1 gene expression in Adriamycin-resistant human breast cancer cells.

Authors:  Ragu Kanagasabai; Karthikeyan Krishnamurthy; Lawrence J Druhan; Govindasamy Ilangovan
Journal:  J Biol Chem       Date:  2011-07-22       Impact factor: 5.157

4.  Evaluation of (64)Cu(DO3A-xy-TPEP) as a potential PET radiotracer for monitoring tumor multidrug resistance.

Authors:  Shuang Liu; Young-Seung Kim; Shizhen Zhai; Jiyun Shi; Guihua Hou
Journal:  Bioconjug Chem       Date:  2009-04       Impact factor: 4.774

5.  Visualization and enrichment of live putative cancer stem cell populations following p53 inactivation or Bax deletion using non-toxic fluorescent dyes.

Authors:  Joshua E Allen; Lori S Hart; David T Dicker; Wenge Wang; Wafik S El-Deiry
Journal:  Cancer Biol Ther       Date:  2009-11-27       Impact factor: 4.742

6.  A cisplatin-resistant head and neck cancer cell line with cytoplasmic p53(mut) exhibits ATP-binding cassette transporter upregulation and high glutathione levels.

Authors:  Manuel Tonigold; Annette Rossmann; Marie Meinold; Michael Bette; Melanie Märken; Katharina Henkenius; Anne C Bretz; Gavin Giel; Chengzhong Cai; Fiona R Rodepeter; Vladimir Beneš; Reidar Grénman; Thomas E Carey; Hermann Lage; Thorsten Stiewe; Andreas Neubauer; Jochen A Werner; Cornelia Brendel; Robert Mandic
Journal:  J Cancer Res Clin Oncol       Date:  2014-06-10       Impact factor: 4.553

7.  A critical dose of doxorubicin is required to alter the gene expression profiles in MCF-7 cells acquiring multidrug resistance.

Authors:  Shang-Hsun Tsou; Tzer-Ming Chen; Hui-Ting Hsiao; Yen-Hui Chen
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

8.  Regulation of MAPKs Signaling Contributes to the Growth Inhibition of 1,7-Dihydroxy-3,4-dimethoxyxanthone on Multidrug Resistance A549/Taxol Cells.

Authors:  Jian Zuo; Hui Jiang; Yan-Hong Zhu; Ya-Qin Wang; Wen Zhang; Jia-Jie Luan
Journal:  Evid Based Complement Alternat Med       Date:  2016-06-15       Impact factor: 2.629

9.  A nanoparticle carrying the p53 gene targets tumors including cancer stem cells, sensitizes glioblastoma to chemotherapy and improves survival.

Authors:  Sang-Soo Kim; Antonina Rait; Eric Kim; Kathleen F Pirollo; Maki Nishida; Natalia Farkas; John A Dagata; Esther H Chang
Journal:  ACS Nano       Date:  2014-05-15       Impact factor: 15.881

Review 10.  Glycosylation in Cancer: Interplay between Multidrug Resistance and Epithelial-to-Mesenchymal Transition?

Authors:  Leonardo Marques da Fonseca; Vanessa Amil da Silva; Leonardo Freire-de-Lima; José Osvaldo Previato; Lucia Mendonça-Previato; Márcia Alves Marques Capella
Journal:  Front Oncol       Date:  2016-06-22       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.